Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease

Missailidis, Catharina, Hällqvist, Jenny, Qureshi, Abdel Rashid, Barany, Peter, Heimbürger, Olof, Lindholm, Bengt, Stenvinkel, Peter, Bergman, Peter·2016·PLOS ONE
DOI 10.1371/journal.pone.0141738

Cited by (340)

Items 101–200 of 340

  1. The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison
    Marie Evans, Lu Dai, Carla María Avesani, Karolina R. Kublickiene, Peter Stenvinkel · 2023 · Clinical Kidney Journal
  2. Allostatic load and ageing: linking the microbiome and nutrition with age-related health
    Paul G. Shiels, Sarah J Buchanan, Colin Selman, Peter Stenvinkel · 2019 · Biochemical Society Transactions
  3. Gut microbiota dysbiosis in AKI to CKD transition
    Saranya Gunasekaran Rajalakshmi, Pragasam Viswanathan · 2023 · Biomedicine & Pharmacotherapy
  4. RapidFire BLAZE-Mode Is Boosting ESI-MS Toward High-Throughput-Screening
    Tom Bretschneider, Can C. Özbal, Markus Holstein, Martin Winter, Frank H. Buettner, Sven Thamm, Daniel Bischoff, Andreas H. Luippold · 2019 · SLAS TECHNOLOGY
  5. Unfavorable Associations Between Serum Trimethylamine N-Oxide and L-Carnitine Levels With Components of Metabolic Syndrome in the Newfoundland Population
    Xiang Gao, Yuan Tian, Edward W. Randell, Haicheng Zhou, Guang Sun · 2019 · Frontiers in Endocrinology
  6. Endometriosis is associated with aberrant metabolite profiles in plasma
    Sophia Letsiou, Dirkje P. Peterse, Amelie Fassbender, Margriet M. W. B. Hendriks, Niels J. F. van den Broek, Rudolf Berger, Dorien F. O, Arne Vanhie, Alexandra Vodolazkaia, Anne Van Langendonckt et al. · 2017 · Fertility and Sterility
  7. Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance
    James J. DiNicolantonio, Mark Frederick McCarty, James Henry O’Keefe · 2019 · Open Heart
  8. Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis
    Jae Jeong Yang, Xiao‐Ou Shu, David M. Herrington, Steven C. Moore, Katie A. Meyer, Jennifer Ose, Cristina Menni, Nicholette D. Palmer, A. Heather Eliassen, Sei Harada et al. · 2020 · American Journal of Clinical Nutrition
  9. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism
    Kelly Lambert, Emanuele Rinninella, Annabel Biruete, Keiichi Sumida, Jordan Stanford, Pauline Celine Raoul, Maria Cristina Mele, Angela Yee-Moon Wang, Denise Mafra · 2023 · Journal of Renal Nutrition
  10. Association of diet with circulating trimethylamine-N-oxide concentration
    Rikuta Hamaya, Kerry Lee Ivey, Dong Hoon Lee, Molin Wang, Jun Li, Adrian A. Franke, Qi Sun, Eric B. Rimm · 2020 · American Journal of Clinical Nutrition
  11. Gut Microbiome and Organ Fibrosis
    Carolina F. F. A. Costa, Benedita Sampaio‐Maia, Ricardo Araújo, Diana Santos Nascimento, Joana Ferreira‐Gomes, Manuel Pestana, Maria João Azevedo, Inês Soares Alencastre · 2022 · Nutrients
  12. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults
    Amanda M. Fretts, Stanley L. Hazen, Paul N. Jensen, Matthew Jay Budoff, Colleen M. Sitlani, Meng Wang, Marcia C. de Oliveira Otto, Joseph A. DiDonato, Yujin Lee, Bruce M. Psaty et al. · 2022 · JAMA Network Open
  13. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis
    Yachun Li, Hongmei Lü, Jing Guo, Meiling Zhang, Huijuan Zheng, Yuning Liu, Weijing Liu · 2023 · Annals of Medicine
  14. Gut microbiota-dependent trimethylamine N-oxide and all-cause mortality: Findings from an updated systematic review and meta-analysis
    Mahdieh Abbasalizad Farhangi · 2020 · Nutrition
  15. The interplay between microbiota‐dependent metabolite trimethylamine N ‐oxide, Transforming growth factor β /SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective
    Omnia Safwat El‐Deeb, Marwa Mohamed Atef, Yasser Mostafa Hafez · 2019 · Journal of Cellular Biochemistry
  16. The metabolomic quest for a biomarker in chronic kidney disease
    Robert Davies · 2018 · Clinical Kidney Journal
  17. Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
    Tu, Ruxin, Xia, Jian · 2024 · CNS & Neurological Disorders - Drug Targets
  18. Targeting the Microbiome in Heart Failure
    Allyson Zabell, W.H. Wilson Tang · 2017 · Current Treatment Options in Cardiovascular Medicine
  19. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease
    Daniel Yuhang Li, W.H. Wilson Tang · 2018 · Seminars in Nephrology
  20. Plant-Based Diets, the Gut Microbiota, and Trimethylamine N-Oxide Production in Chronic Kidney Disease: Therapeutic Potential and Methodological Considerations
    Gretchen N. Wiese, Annabel Biruete, Ranjani N. Moorthi, Sharon M. Moe, Stephen R. Lindemann, Kathleen M. Hill Gallant · 2020 · Journal of Renal Nutrition
  21. Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
    Sophie Liabeuf, Lynda Cheddani, Ziad A. Massy · 2018 · Toxins
  22. Protective Effects of Black Raspberry (Rubus occidentalis) Extract against Hypercholesterolemia and Hepatic Inflammation in Rats Fed High-Fat and High-Choline Diets
    Taehwan Lim, Juhee Ryu, Kiuk Lee, Sun Young Park, Keum Taek Hwang · 2020 · Nutrients
  23. Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy
    Shan Lu, Chunling Wang, Jingru Ma, Yichao Wang · 2024 · Frontiers in Immunology
  24. Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis
    Jae Woong Jang, Emma Capaldi, Tracy L. Smith, Priyanka Verma, John Varga, Karen J. Ho · 2024 · Molecular Medicine
  25. Biomarkers for predicting outcomes in chronic kidney disease
    Sri Lekha Tummalapalli, Girish N. Nadkarni, Steven G. Coca · 2016 · Current Opinion in Nephrology & Hypertension
  26. Is increased plasma TMAO a compensatory response to hydrostatic and osmotic stress in cardiovascular diseases?
    Marcin Ufnal, Artur Nowiński · 2019 · Medical Hypotheses
  27. Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation
    Lisard Iglesias‐Carres, Michael D. Hughes, Cortney N. Steele, Monica A. Ponder, Kevin P. Davy, Andrew Peter Neilson · 2021 · The Journal of Nutritional Biochemistry
  28. Trimethylamine N-Oxide (TMAO) Impairs Purinergic Induced Intracellular Calcium Increase and Nitric Oxide Release in Endothelial Cells
    Giulia Querio, Susanna Antoniotti, Federica Geddo, Renzo Cesare Levi, Maria Pia Gallo · 2022 · International Journal of Molecular Sciences
  29. The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It’s Not All Bad
    Emily S. Krueger, Trevor S. Lloyd, Jeffery S. Tessem · 2021 · Nutrients
  30. Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease
    Zhonghong Yan, Guanran Wang, Xingyang Shi · 2021 · Frontiers in Pharmacology
  31. Protein Intake at Twice the RDA in Older Men Increases Circulatory Concentrations of the Microbiome Metabolite Trimethylamine-N-Oxide (TMAO)
    Sarah M. Mitchell, Amber Marie Milan, Cameron J. Mitchell, Nicola A. Gillies, Randall F. D’Souza, Nina Zeng, Farha Ramzan, Pankaja Sharma, Scott O. Knowles, Nicole Clemence Roy et al. · 2019 · Nutrients
  32. The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy
    Xiaowei Xiong, Jian Wei Zhou, Qiang Fu, Xiaowei Xu, Shaobin Wei, Shenghua Yang, Buxing Chen · 2022 · Lipids in Health and Disease
  33. Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: A double-blind, randomized, placebo-controlled trial
    Amanda de Faria Barros, Natália Alvarenga Borges, Lia S. Nakao, Carla Juliana Ribeiro Dolenga, Flávia Lima do Carmo, Dennis de Carvalho Ferreira, Peter Stenvinkel, Peter Bergman, Bengt Lindholm, Denise Mafra · 2018 · Journal of Functional Foods
  34. Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system
    Maksymilian Onyszkiewicz, Kinga Jaworska, Marcin Ufnal · 2020 · Experimental Biology and Medicine
  35. TMAO and diabetes: from the gut feeling to the heart of the problem
    Kinga Jaworska, Monika Kuś, Marcin Ufnal · 2025 · Nutrition and Diabetes
  36. The effect of trimethylamine N-oxide on Helicobacter pylori-induced changes of immunoinflammatory genes expression in gastric epithelial cells
    Daoyan Wu, Mei Cao, Jingshan Peng, Ningzhe Li, Sijun Yi, Liju Song, Xuege Wang, Mao Zhang, Jian Zhao · 2016 · International Immunopharmacology
  37. Trimethylamine N-oxide and the reverse cholesterol transport in cardiovascular disease: a cross-sectional study
    Laura Bordoni, Joanna J. Samulak, Angelika Katarzyna Sawicka, Iwona Pelikant‐Małecka, Adrianna Radulska, Łukasz Lewicki, Leszek Kalinowski, Rosita Gabbianelli, Robert Antoni Olek · 2020 · Scientific Reports
  38. Changes in gut microbial community upon chronic kidney disease
    Wu Liu, Jiaqi Huang, Tong Liu, Yutian Hu, Kaifeng Shi, Yi Zhou, Ning Zhang · 2023 · PLoS ONE
  39. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria
    Signe Abitz Winther, Jens Oellgaard, Tine W. Hansen, Bernt Johan von Scholten, Henrik Reinhard, Tarunveer S. Ahluwalia, Zeneng Wang, Peter Gæde, Hans‐Henrik Parving, Stanley L. Hazen et al. · 2021 · PLoS ONE
  40. Attenuation of Circulating Trimethylamine N-Oxide Prevents the Progression of Cardiac and Renal Dysfunction in a Rat Model of Chronic Cardiorenal Syndrome
    Deling Zou, Yanyu Li, Guangping Sun · 2021 · Frontiers in Pharmacology
  41. OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction
    Michele Provenzano, Raffaele Serra, Carlo Garofalo, Ashour Michael, Giuseppina Crugliano, Yuri Battaglia, Nicola Ielapi, Umberto Marcello Bracale, Teresa Faga, Giulia Capitoli et al. · 2021 · International Journal of Molecular Sciences
  42. Metabolomics in chronic kidney disease: Strategies for extended metabolome coverage
    Yoric Gagnebin, Julien Boccard, Belén Ponte, Serge L. Rudaz · 2018 · Journal of Pharmaceutical and Biomedical Analysis
  43. The Role of Betaine in Patients With Chronic Kidney Disease: a Narrative Review
    Lívia Alvarenga, Maira Silva Ferreira, Julie Ann Kemp, Denise Mafra · 2022 · Current Nutrition Reports
  44. Elevated trimethylamine‐N ‐oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function
    Martin Kummen, Mette Nåmdal Vesterhus, Marius Trøseid, Bjørn Allan Moum, Asbjørn M. Svardal, Kirsten Muri Boberg, Pål Aukrust, Tom H. Karlsen, Rolf Kristian Berge, Johannes R. Hov · 2016 · United European Gastroenterology Journal
  45. Probiotic interventions in peritoneal dialysis: A review of underlying mechanisms and therapeutic potentials
    Natalia Stepanova · 2024 · World Journal of Nephrology
  46. The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages
    Catharina Missailidis, Ujjwal Neogi, Peter Stenvinkel, Marius Trøseid, Piotr Nowak, Peter Bergman · 2018 · AIDS
  47. An Update of Urine and Blood Metabolomics in Chronic Kidney Disease
    Shiva Kalantari, Mohsen Nafar · 2019 · Biomarkers in Medicine
  48. Persistent metabolomic alterations characterize chronic critical illness after severe trauma
    Dara L. Horn, Lisa Bettcher, Sandi L. Navarro, Vadim Pascua, Fausto Carnevale Neto, Joseph Cuschieri, Daniel Raftery, Grant Edward O’Keefe · 2020 · The Journal of Trauma: Injury, Infection, and Critical Care
  49. Associations between physical activity and trimethylamine N -oxide in those at risk of type 2 diabetes
    Stavroula Argyridou, Dennis Bernieh, Joseph J. Henson, Charlotte Louise Edwardson, Melanie Jane Davies, Kamlesh K. Khunti, Toru Suzuki, Thomas E. Yates · 2020 · BMJ Open Diabetes Research & Care
  50. Gut Metabolite Trimethylamine N-Oxide Protects INS-1 β-Cell and Rat Islet Function under Diabetic Glucolipotoxic Conditions
    Emily S. Krueger, Joseph L. Beales, Kacie B. Russon, Weston S. Elison, Jordan Davis, Jackson M. Hansen, Andrew Peter Neilson, Jason M. Hansen, Jeffery S. Tessem · 2021 · Biomolecules
  51. Circulating Trimethylamine-N-Oxide and Risk of All-Cause and Cardiovascular Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Zhongwei Zhou, Hao Jin, Huixiang Ju, Mingzhong Sun, Hongmei Chen, Li Li · 2022 · Frontiers in Medicine
  52. Time-dependent specific molecular signatures of inflammation and remodelling are associated with trimethylamine-N-oxide (TMAO)-induced endothelial cell dysfunction
    Meyammai Shanmugham, Arun George Devasia, Yu Ling Chin, Kang Hao Cheong, Eng Shi Ong, Sophie Bellanger, Adaikalavan Ramasamy, Chen Huei Leo · 2023 · Scientific Reports
  53. Intestinal microbiota and kidney diseases
    Myung-Gyu Kim, Jihyun Yang, Sang‐Kyung Jo · 2021 · Kidney Research and Clinical Practice
  54. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality
    Agnė Laučytė-Cibulskienė, Liam J. Ward, Thomas Ebert, Giulia Tosti, Claudia Tucci, Leah N. Hernandez, Alexandra Kautzky‐Willer, María Trinidad Herrero, Colleen M. Norris, Louise Pilote et al. · 2021 · Biology of Sex Differences
  55. Microbiome in Chronic Kidney Disease
    Theodoros Tourountzis, Γεώργιος Λιούλιος, Asimina Fylaktou, Eleni Moysidou, Aikaterini A. Papagianni, Maria J. Stangou · 2022 · Life
  56. Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria
    Maud Bollenbach, Manuel A. Ortega, Marina Orman, Catherine Luschinsky Drennan, Emily P. Balskus · 2020 · ACS Medicinal Chemistry Letters
  57. Trimethylamine-N-oxide acutely increases cardiac muscle contractility
    Carlee I. Oakley, Julian A. Vallejo, Derek D. Wang, Mark Gray, LeAnn M. Tiede-Lewis, Tilitha Shawgo, Emmanuel Daon, George L. Zorn, Jason R. Stubbs, Michael Wacker · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
  58. Toll-Like Receptor 4: A Macrophage Cell Surface Receptor Is Activated By Trimethylamine-N-Oxide.
    Mohammad Saeed Hakhamaneshi, Alina Abdolahi, Zakaria Vahabzadeh, Mohammad Abdi, Pedram Andalibi · 2021 · PubMed Central
  59. Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bears
    T. Ebert, J. Painer, P. Bergman, A. Qureshi, Sylvain Giroud, Gabrielle Stalder, K. Kublickiene, F. Göritz, Sebastian G. Vetter, C. Bieber et al. · 2020 · Scientific Reports
  60. Tissue Factor, Thrombosis, and Chronic Kidney Disease
    Yuji Oe, Nobuyuki Takahashi · 2022 · Biomedicines
  61. Applying mass spectrometry-based assays to explore gut microbial metabolism and associations with disease
    Liam M. Heaney · 2019 · Clinical Chemistry and Laboratory Medicine (CCLM)
  62. Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a Multifaceted Biomarker in Cardiovascular Disease: Challenges and Opportunities
    Kinga Jaworska, Wojciech Kopacz, Mateusz Koper, Marcin Ufnal · 2024 · International Journal of Molecular Sciences
  63. Modulation of Circulating Trimethylamine N-Oxide Concentrations by Dietary Supplements and Pharmacological Agents: A Systematic Review
    Nora A. Kalagi, Kylie A. Abbott, Khalid A. Alburikan, Hadeel Alkofide, Elizabeth Stojanovski, Manohar L. Garg · 2019 · Advances in Nutrition
  64. Two Gut Microbiota-Derived Toxins Are Closely Associated with Cardiovascular Diseases: A Review
    Tomoya Yamashita, Naofumi Yoshida, Takuo Emoto, Yoshihiro Saito, Ken‐ichi Hirata · 2021 · Toxins
  65. wild-type choline TMA lyase in complex with betaine aldehyde
    Michael A. Funk, Catherine Luschinsky Drennan · 2018 · Worldwide Protein Data Bank
  66. Trimethylamine N-oxide—a marker for atherosclerotic vascular disease
    Guinan Xie, Yan An, Peng Lin, Yi Wang, Liping Guo · 2021 · Reviews in Cardiovascular Medicine
  67. From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge
    Jialun Zhang, Peining Zhu, Siyu Li, Yufei Gao, Yue Xing · 2023 · Frontiers in Pharmacology
  68. Trimethylamine N-oxide in cardiovascular disease: Pathophysiology and the potential role of statins
    Fakhar Latif, Ayesha Mubbashir, Muhammad Sohaib Khan, Zain Shaikh, Aaima Memon, Jenelle Alvares, Ayesha Azhar, Hritvik Jain, Raheel Ahmed, Sai Gautham Kanagala · 2024 · Life Sciences
  69. Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis
    melana yuzefpolskaya, Bruno Bohn, Azka Javaid, Giulio M. Mondellini, Lorenzo Braghieri, Alberto Pinsino, Duygu Onat, Barbara Cagliostro, Andrea D. Kim, Koji Takeda et al. · 2021 · Circulation Heart Failure
  70. Renal function is associated with plasma trimethylamine-N-oxide, choline, l-carnitine and betaine: a pilot study
    Fei Guo, Qing Dai, Xiangchang Zeng, Yan Liu, Zhi‐Rong Tan, Hao Zhang, Dongsheng Ouyang · 2020 · International Urology and Nephrology
  71. Effects of acute administration of trimethylamine N-oxide on endothelial function: a translational study
    Anne Jomard, Luca Liberale, Petia Doytcheva, Martin F. Reiner, Daniel Müller, Michele Visentin, Marco Bueter, Thomas Felix Lüscher, Roberto Vettor, Thomas A. Lutz et al. · 2022 · Scientific Reports
  72. Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link
    Biki Saha, Antara Banerjee, Rupak Pathak, Asim K. Duttaroy, Surajit Pathak · 2025 · Biomedicine & Pharmacotherapy
  73. Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes
    Nora A. Kalagi, Rohith N. Thota, Elizabeth Stojanovski, Khalid A. Alburikan, Manohar L. Garg · 2023 · Nutrients
  74. The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis
    Yujie Zhu, Yu-Chen Lai, Yuxuan Hu, Yiwen Fu, Zheng Zhang, Nan Lin, Wei Huang, Lemin Zheng · 2024 · Biomedicine & Pharmacotherapy
  75. Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1
    Catharina Missailidis, Nikolaj Sørensen, Senait Ashenafi, Wondwossen Amogne, Endale Kassa, Amsalu Bekele, Meron Getachew, Nebiat G. Gebreselassie, Abraham Aseffa, Getachew Aderaye et al. · 2019 · Nutrients
  76. The MttB superfamily member MtyB from the human gut symbiont Eubacterium limosum is a cobalamin-dependent γ-butyrobetaine methyltransferase
    Jared Ellenbogen, Ruisheng Jiang, Duncan J. Kountz, Liwen Zhang, Joseph Adrian Krzycki · 2021 · Journal of Biological Chemistry
  77. Microbial Metabolites in the Maturation and Activation of Dendritic Cells and Their Relevance for Respiratory Immunity
    Kayla R. Wilson, Elise Gressier, Malcolm John McConville, Sammy Bedoui · 2022 · Frontiers in Immunology
  78. The microbial metabolite trimethylamine N-oxide and the kidney diseases
    Jian Qiang Su, Xiangqi Wu, Qi Wang, Bo-Yang Xie, Cui-Yan Xiao, Hong-yong Su, Ji‐Xin Tang, Cuiwei Yao · 2025 · Frontiers in Cellular and Infection Microbiology
  79. Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Ceren Eyileten, Joanna Jarosz-Popek, Daniel Jakubik, Aleksandra Gąsecka, Marta Wolska, Marcin Ufnal, Marek A Postula, Aurel Toma, Irene Marthe Lang, Jolanta Maria Siller-Matula · 2021 · Frontiers in Cardiovascular Medicine
  80. Suyin Detoxification Granule alleviates trimethylamine N-oxide–induced tubular ferroptosis and renal fibrosis to prevent chronic kidney disease progression
    Hongwei Ge, Yuan Wei, Wentao Zhang, Yong Chen, Yanlin Chen, Enchao Zhou · 2024 · Phytomedicine
  81. Uremic Toxin–Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome
    Kensei Taguchi, Bertha C. Elias, Craig R. Brooks, Seiji Ueda, Kei Fukami · 2019 · Circulation Journal
  82. Socioeconomic position links circulatory microbiota differences with biological age
    Craven, Hannah, McGuinness, Dagmara, Buchanan, Sarah, Galbraith, Norman, McGuinness, David H., Jones, Brian, Combet, Emilie, Mafra, Denise, Bergman, Peter, Ellaway, Anne et al. · 2021 · Scientific Reports
  83. Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients
    Bang‐Gee Hsu, Chih‐Hsien Wang, Yu‐Li Lin, Yu-Hsien Lai, Jen‐Pi Tsai · 2022 · Toxins
  84. Fish oil affects the metabolic process of trimethylamine N-oxide precursor through trimethylamine production and flavin-containing monooxygenase activity in male C57BL/6 mice
    Jie Yu, Tiantian Zhang, Xiang Gao, Changhu Xue, Jie Xu, Yuming Wang · 2017 · RSC Advances
  85. Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study
    Jonathan Shea, David R. Jacobs, Annie Green Howard, Anju Lulla, Donald M. Lloyd‐Jones, Venkatesh Locharla Murthy, Ravi V. Shah, Isis Trujillo‐Gonzalez, Penny Gordon‐Larsen, Katie A. Meyer · 2023 · American Journal of Clinical Nutrition
  86. Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review
    Soumik Das, Vijayarangan Devi Rajeswari, Ganesh Venkatraman, Ramprasad Elumalai, Dhanasekaran Sivaraman, Gnanasambandan Ramanathan · 2023 · Translational research
  87. Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease
    Yi Zhen Han, Huijuan Zheng, Bo Xuan Du, Yi Zhang, Xing Yu Zhu, Jing Li, Yaoxian Wang, Wei Jing Liu · 2023 · Journal of Diabetes Research
  88. Capillary electrophoresis with dual diode array detection and tandem mass spectrometry to access cardiovascular biomarkers candidates in human urine: Trimethylamine-N-Oxide and l-carnitine
    Zuzana Cieslarová, Mariana Magaldi, Lucélia Alcantara Barros, Claudimir Lúcio do Lago, Daniel Rossado Oliveira, Francisco Antônio Helfenstein Fonseca, Maria Cristina de Oliveira Izar, Aline Soriano Lopes, Marina Franco Maggi Tavares, Aline Klassen · 2018 · Journal of Chromatography A
  89. The Protective Effect of Basic Fibroblast Growth Factor on Diabetic Nephropathy Through Remodeling Metabolic Phenotype and Suppressing Oxidative Stress in Mice
    Tingting Wei, Qi Shu, Jie Ning, Shuaijie Wang, Chen Li, Liangcai Zhao, Hong Xing Zheng, Hongchang Gao · 2020 · Frontiers in Pharmacology
  90. The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease
    Sai Pan, Delong Zhao, Shuwei Duan, Xiangmei Chen · 2023 · International Urology and Nephrology
  91. Integrative metabolomic profiling reveals aberrations in myometrium associated with adenomyosis: a pilot study
    Wei Song, Zhibo Zhang, Ying Jiang, Yang Cao, Bo Zhang, Yujie Wang, Honghui Shi, Lan Zhu · 2022 · Reproductive Biology and Endocrinology
  92. Sex‐Associated Metabolites and Incident Stroke, Incident Coronary Heart Disease, Hypertension, and Chronic Kidney Disease in the REGARDS Cohort
    Catharine A. Couch, Zsuzsanna Ament, Amit Patki, Naruchorn Kijpaisalratana, Varun M. Bhave, Alana C Jones, Nicole D. Armstrong, Mary Cushman, William Taylor Kimberly, Marguerite R. Irvin · 2024 · Journal of the American Heart Association
  93. Chemical Derivatization Enables MALDI-TOF-Based High-Throughput Screening for Microbial Trimethylamine (TMA)-Lyase Inhibitors
    Martin Winter, Tom Bretschneider, Sven Thamm, Carola Kleiner, Daniel Grabowski, Sarah Chandler, Robert Ries, Jörg Thomas Kley, Danielle Fowler, Christina Bartlett et al. · 2019 · SLAS DISCOVERY
  94. The Presence of High Levels of Circulating Trimethylamine N-Oxide Exacerbates Central and Peripheral Inflammation and Inflammatory Hyperalgesia in Rats Following Carrageenan Injection
    Yanan Zhang, Chunlian Zhang, Haiou Li, Jingdong Hou · 2019 · Inflammation
  95. Blood Plasma Metabolites in Diabetes-Associated Chronic Kidney Disease: A Focus on Lipid Profiles and Cardiovascular Risk
    A. Lecamwasam, T. Mansell, E. Ekinci, R. Saffery, K. Dwyer · 2022 · Frontiers in Nutrition
  96. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
    Raúl Sánchez-Giménez, Óscar M. Peiró, Gil Bonet, Anna Carrasquer, Georgios A. Fragkiadakis, Mònica Bulló, Christopher Papandreou, Alfredo Bardajı́ · 2022 · Frontiers in Cardiovascular Medicine
  97. Higher serum trimethylamine-N-oxide levels are associated with increased abdominal aortic calcification in hemodialysis patients
    He Lian, Wenling Yang, Ping Yang, Xianhua Zhang, Aihua Zhang · 2022 · Renal Failure
  98. Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency
    Adriana Mika, Wojciech Wojtowicz, Adam Ząbek, Piotr Młynarz, Michael S. Chmielewski, Tomasz Śledziński, Piotr Stepnowski · 2017 · Journal of Pharmaceutical and Biomedical Analysis
  99. Gut Microbial Metabolites As Mediators of Renal Disease: do Short-Chain Fatty Acids Offer Some Hope?
    Liam M. Heaney, Owen G. Davies, Nicholas M. Selby · 2019 · Future Science OA
  100. Gut microbiota metabolites and risk of major adverse cardiovascular events and death: A systematic review and meta-analysis
    Qaisar Ali Khan, Muhammad Asad, Abdul Hannan Ali, Ameer Mustafa Farrukh, Usama Naseem, Bader Semakieh, Yaxel Levin-Carrion, Muhammad Afzal · 2024 · Medicine